Psychopharmacology is an international journal of research and scholarship, the aims of which are to cover the general area of elucidating the neurochemical mechanisms that affect behavior, all terms understood in the broadest sense. The scope of the Journal extends from clinical psychopharmacology (including trials), to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies (techniques covered) may range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry. The journal is particularly interested in articles that integrate these levels of analysis.

Human Psychopharmacology: Experimental
For North and South America
Principal editor
H. de Wit, Chicago
Advisory editors
M. Haney, New York
E. London, Los Angeles
K.A. Perkins, Pittsburgh
K. Preston, Baltimore
For the rest of the world
Principal editor
V.H. Curran, London
Advisory editors
B. Becker, Chengdu
G. Bedi, Parkville
M.A. Mehta, London
N. Solowij, Wollongong

Human Psychopharmacology: Clinical and Translational
For North and South America
Principal editor
D.C. D'Souza, New Haven
Advisory editors
C.G. Abdallah, New Haven
A. Abi-Dargham, New York
S.J. Mathew, Houston
C.J. McDougle, Boston

For the rest of the world
Principal editor
O. Howes, London
Advisory editors
A. Heinz, Berlin
C. Pantelis, Melbourne
H. Uchida, Tokyo

Preclinical Psychopharmacology: Behavioral and Neural
For North and South America
Principal editor
P.H. Janak, Baltimore
Advisory editors
S.L. Andersen, Belmont
F.S. Guimaraes, Ribeirao Preto
J.D. Jentsch, Binghampton
E.M. Jutkiewicz, Ann Arbor
T.J. Phillips, Portland
M. Picciotto, New Haven
Y. Shaham, Baltimore

For the rest of the world
Principal editor
T.W. Robbins, Cambridge
Advisory editors
D. Belin, Cambridge
B. Ellenbroek, Wellington
C. Müller, Erlangen
T. Nabeshima, Nagoya
J. Neill, Manchester
E. Robinson, Bristol
L. Vanderschuren, Utrecht

Preclinical Psychopharmacology: Translational
For North and South America
Principal editor
S. Floresco, Vancouver
Advisory Editors
A. Holmes, Bethesda
J.L. Neisewander, Tempe
N.R. Swerdlow, La Jolla
For the rest of the world
Principal editor
C. Baunez, Marseille
Advisory editors
A. Bespalov, Heidelberg
M. Cador, Bordeaux
K. Fone, Nottingham
M.W. Jones, Bristol
M. Naassila, Amiens
D.A. Slattery, Frankfurt a. M.

Preclinical Psychopharmacology: Molecular, Genetic and Epigenetic
For North and South America
Principal editor
A.L. Morrow, Chapel Hill
Advisory editors
J.F. McGinty, Charleston
D.L. Robinson, Chapel Hill
B.L. Roth, Chapel Hill

For the rest of the world
Principal editor
K. Hashimoto, Chiba
Advisory editors
S. Chaki, Saitama
J.F. Cryan, Cork
D. Inta, Basel
A. Lawrence, Melbourne
M.C. Pardon, Nottingham
Marco Riva, Milan
W. Zhou, Ningbo